Supriya Lifescience Limited (NSE:SUPRIYA)

Supriya Lifescience Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Operating Revenue	7,147	6,965	5,703	4,609	5,300	3,912
Revenue	7,147	6,965	5,703	4,609	5,300	3,912
Revenue Growth (YoY)	14.35%	22.12%	23.73%	-13.04%	35.49%	22.25%
Cost of Revenue	2,272	2,343	2,322	1,961	2,035	1,329
Gross Profit	4,875	4,622	3,381	2,649	3,266	2,583
Selling, General & Admin	933.49	859.5	724.21	730.21	655.81	501.41
Other Operating Expenses	1,361	1,153	896.37	628.48	465.44	350.31
Operating Expenses	2,536	2,217	1,779	1,477	1,222	919.33
Operating Income	2,339	2,405	1,602	1,172	2,043	1,664
Interest Expense	-6.46	-4.81	-35.91	-30.84	-41.98	-40.8
Interest & Investment Income	40.19	40.19	83.57	95.16	70.94	49.91
Other Non Operating Income (Expenses)	-6.72	-13.29	-15.56	-0.02	0.1	0.13
EBT Excluding Unusual Items	2,366	2,427	1,635	1,236	2,072	1,673
Gain (Loss) on Sale of Investments	55.65	55.65	22.4	-	-	-
Gain (Loss) on Sale of Assets	-	-	-	-1.11	-	-
Pretax Income	2,424	2,485	1,657	1,235	2,072	1,673
Income Tax Expense	599.9	605.23	465.76	336.3	554.35	437.16
Net Income	1,824	1,880	1,191	898.57	1,518	1,236
Net Income to Common	1,824	1,880	1,191	898.57	1,518	1,236
Net Income Growth	15.79%	57.80%	32.56%	-40.81%	22.83%	68.38%
Shares Outstanding (Basic)	80	80	80	80	80	73
Shares Outstanding (Diluted)	80	80	80	80	80	73
Shares Change (YoY)	-0.28%	-	-	-	9.97%	-
EPS (Basic)	22.69	23.35	14.80	11.16	18.86	16.89
EPS (Diluted)	22.69	23.35	14.80	11.16	18.86	16.89
EPS Growth	16.10%	57.77%	32.62%	-40.83%	11.68%	68.38%
Free Cash Flow	-7.22	22.99	-323.48	-443.05	-111.03	276.48
Free Cash Flow Per Share	-0.09	0.29	-4.02	-5.50	-1.38	3.78
Dividend Per Share	-	1.000	0.800	0.600	0.600	0.540
Dividend Growth	-	25.00%	33.33%	-	11.11%	-73.00%
Gross Margin	68.21%	66.36%	59.28%	57.46%	61.61%	66.03%
Operating Margin	32.72%	34.53%	28.10%	25.42%	38.55%	42.53%
Profit Margin	25.52%	26.99%	20.89%	19.49%	28.64%	31.59%
Free Cash Flow Margin	-0.10%	0.33%	-5.67%	-9.61%	-2.10%	7.07%
EBITDA	2,572	2,601	1,752	1,281	2,136	1,724
EBITDA Margin	35.98%	37.34%	30.72%	27.80%	40.31%	44.06%
D&A For EBITDA	233.05	196.15	149.62	109.7	93.01	60
EBIT	2,339	2,405	1,602	1,172	2,043	1,664
EBIT Margin	32.72%	34.53%	28.10%	25.42%	38.55%	42.53%
Effective Tax Rate	24.75%	24.36%	28.11%	27.23%	26.75%	26.13%
Revenue as Reported	7,251	7,063	5,810	4,704	5,376	3,962
Advertising Expenses	-	53.82	47.34	173.92	165.03	173.8

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.